TNF and melanoma: The linear mixed-effects analysis examined TNF-α levels over time (baseline, 3 months, 6 months) across the two cancer types (melanoma vs. NSCLC) and included random intercepts for each participant and accounted for autocorrelation with an AR (1) residual structure.